Avadel Pharmaceuticals (AVDL) Change in Receivables: 2015-2020
Historic Change in Receivables for Avadel Pharmaceuticals (AVDL) over the last 6 years, with Sep 2020 value amounting to -$5.7 million.
- Avadel Pharmaceuticals' Change in Receivables fell 293.37% to -$5.7 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$8.7 million, marking a year-over-year decrease of 1982.58%. This contributed to the annual value of $22.0 million for FY2024, which is 81.72% up from last year.
- Avadel Pharmaceuticals' Change in Receivables amounted to -$5.7 million in Q3 2020, which was down 83.26% from -$3.1 million recorded in Q2 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Change in Receivables peaked at $5.9 million during Q3 2016, and registered a low of -$9.3 million during Q4 2017.
- In the last 3 years, Avadel Pharmaceuticals' Change in Receivables had a median value of -$1.4 million in 2019 and averaged -$1.3 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Change in Receivables skyrocketed by 316.06% in 2016, and later slumped by 478.42% in 2017.
- Over the past 5 years, Avadel Pharmaceuticals' Change in Receivables (Quarterly) stood at $2.5 million in 2016, then plummeted by 478.42% to -$9.3 million in 2017, then soared by 117.29% to $1.6 million in 2018, then plummeted by 127.69% to -$445,000 in 2019, then tumbled by 293.37% to -$5.7 million in 2020.
- Its Change in Receivables was -$5.7 million in Q3 2020, compared to -$3.1 million in Q2 2020 and $517,000 in Q1 2020.